ZNF629

gene
On this page

Also known as KIAA0326

Summary

ZNF629 (zinc finger protein 629, HGNC:29008) is a protein-coding gene on chromosome 16p11.2, encoding Zinc finger protein 629 (Q9UEG4). May be involved in transcriptional regulation.

Predicted to enable DNA binding activity and zinc ion binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus.

Source: NCBI Gene 23361 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 105 total
  • MANE Select transcript: NM_001080417

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:29008
Approved symbolZNF629
Namezinc finger protein 629
Location16p11.2
Locus typegene with protein product
StatusApproved
AliasesKIAA0326
Ensembl geneENSG00000102870
Ensembl biotypeprotein_coding
OMIM619587
Entrez23361

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000262525, ENST00000896341

RefSeq mRNA: 2 — MANE Select: NM_001080417 NM_001080417, NM_001345970

CCDS: CCDS45463

Canonical transcript exons

ENST00000262525 — 3 exons

ExonStartEnd
ENSE000006825973077845630784254
ENSE000006825983078441030784515
ENSE000006826063078702830787205

Expression profiles

Bgee: expression breadth ubiquitous, 278 present calls, max score 92.10.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.1289 / max 73.4863, expressed in 1743 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
15709213.76521743
1570910.3637179

Top tissues by expression

295 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
type B pancreatic cellCL:000016992.10gold quality
olfactory bulbUBERON:000226491.97gold quality
diaphragmUBERON:000110389.77silver quality
tendon of biceps brachiiUBERON:000818887.40gold quality
apex of heartUBERON:000209885.58gold quality
endometrium epitheliumUBERON:000481185.16gold quality
paraflocculusUBERON:000535184.52gold quality
nasal cavity epitheliumUBERON:000538484.47gold quality
cortical plateUBERON:000534383.96gold quality
tibialis anteriorUBERON:000138583.53silver quality
left ventricle myocardiumUBERON:000656683.48silver quality
endothelial cellCL:000011583.39silver quality
ganglionic eminenceUBERON:000402382.73gold quality
lateral nuclear group of thalamusUBERON:000273682.65gold quality
heart left ventricleUBERON:000208482.61gold quality
cardiac ventricleUBERON:000208282.56gold quality
heart right ventricleUBERON:000208082.45gold quality
middle frontal gyrusUBERON:000270282.41gold quality
cardiac muscle of right atriumUBERON:000337982.30gold quality
ventricular zoneUBERON:000305382.26gold quality
inferior olivary complexUBERON:000212781.99gold quality
frontal poleUBERON:000279581.94gold quality
embryoUBERON:000092281.57gold quality
stromal cell of endometriumCL:000225581.44gold quality
medial globus pallidusUBERON:000247781.41gold quality
quadriceps femorisUBERON:000137781.36silver quality
Brodmann (1909) area 10UBERON:001354181.20gold quality
CA1 field of hippocampusUBERON:000388180.85silver quality
deltoidUBERON:000147680.83silver quality
heartUBERON:000094880.63gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-GEOD-100618yes258.96
E-ANND-3no3.09

Regulation

Is transcription factor: no

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusZfp629ENSMUSG00000045639
rattus_norvegicusZfp629ENSRNOG00000018877

Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631), ZNF3 (ENSG00000166526)

Protein

Protein identifiers

Zinc finger protein 629Q9UEG4 (reviewed: Q9UEG4)

Alternative names: Zinc finger protein 65

All UniProt accessions (1): Q9UEG4

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

RefSeq proteins (2): NP_001073886, NP_001332899 (=MANE)

Domains & families (InterPro)

IDNameType
IPR013087Znf_C2H2_typeDomain
IPR036236Znf_C2H2_sfHomologous_superfamily
IPR050758Znf_C2H2-typeFamily

Pfam: PF00096

UniProt features (34 total): zinc finger region 19, compositionally biased region 4, cross-link 4, region of interest 3, modified residue 2, chain 1, sequence variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9UEG4-F164.330.13

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (6): 18, 616, 251, 688, 750, 840

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 135 (showing top): KOYAMA_SEMA3B_TARGETS_UP, chr16p11, HAMAI_APOPTOSIS_VIA_TRAIL_DN, SAFFORD_T_LYMPHOCYTE_ANERGY, SENESE_HDAC3_TARGETS_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP, KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN, MARTENS_TRETINOIN_RESPONSE_DN, LU_EZH2_TARGETS_UP, KRIEG_HYPOXIA_NOT_VIA_KDM3A, IL2_UP.V1_DN, IL21_UP.V1_DN, DIDO1_TARGET_GENES, FOXD2_TARGET_GENES

GO Biological Process (1): regulation of transcription by RNA polymerase II (GO:0006357)

GO Molecular Function (4): DNA binding (GO:0003677), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription1
transcription by RNA polymerase II1
nucleic acid binding1
transition metal ion binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

2092 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF629TRIM28Q13263981
ZNF629ZUP1Q96AP4856
ZNF629USP5P45974819
ZNF629UBBP02248811
ZNF629YOD1Q5VVQ6788
ZNF629USP44Q9H0E7773
ZNF629OTUD7AQ8TE49740
ZNF629SETDB1Q15047673
ZNF629ZPR1O75312670
ZNF629CRBNQ96SW2663
ZNF629HDAC6Q9UBN7653
ZNF629UBA2Q9UBT2647
ZNF629PHF20Q9BVI0638
ZNF629NPLOC4Q8TAT6568
ZNF629ZFAND5O76080558

IntAct

155 interactions, top by confidence:

ABTypeScore
YWHABPIK3C2Apsi-mi:“MI:0914”(association)0.800
GTF3C3POLR3Dpsi-mi:“MI:0914”(association)0.640
YWHAGBLTP3Bpsi-mi:“MI:0914”(association)0.640
IPO8TRIM28psi-mi:“MI:0914”(association)0.640
LIN28AIGF2BP3psi-mi:“MI:0914”(association)0.640
YWHAEPIK3C2Apsi-mi:“MI:0914”(association)0.570
YWHAHBLTP3Bpsi-mi:“MI:0914”(association)0.570
YWHAZPIK3C2Apsi-mi:“MI:0914”(association)0.570
ZNF629YJU2Bpsi-mi:“MI:0915”(physical association)0.560
ZNF629TEPSINpsi-mi:“MI:0915”(physical association)0.560
ZNF629PPP1CCpsi-mi:“MI:0915”(physical association)0.560
ZNF629psi-mi:“MI:0915”(physical association)0.560
CCHCR1ZNF629psi-mi:“MI:0915”(physical association)0.560
CDR2LZNF629psi-mi:“MI:0915”(physical association)0.560
HNF4GZNF629psi-mi:“MI:0915”(physical association)0.560
ZNF629ZRANB1psi-mi:“MI:0915”(physical association)0.560
GOLGA6L9ZNF629psi-mi:“MI:0915”(physical association)0.560
GAS8ZNF629psi-mi:“MI:0915”(physical association)0.560
LDOC1ZNF629psi-mi:“MI:0915”(physical association)0.560
TRIM41ZNF629psi-mi:“MI:0915”(physical association)0.560
ZNF438ZNF629psi-mi:“MI:0915”(physical association)0.560
JRKZNF629psi-mi:“MI:0915”(physical association)0.560
SMARCD1ZNF629psi-mi:“MI:0915”(physical association)0.560
SPG21ZNF629psi-mi:“MI:0915”(physical association)0.560
ZNF629RSPH14psi-mi:“MI:0915”(physical association)0.560
ZNF629ISY1psi-mi:“MI:0915”(physical association)0.560
TEPSINZNF629psi-mi:“MI:0915”(physical association)0.560
YJU2BZNF629psi-mi:“MI:0915”(physical association)0.560

BioGRID (141): ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Proximity Label-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-MS), ZNF629 (Affinity Capture-RNA)

ESM2 similar proteins: A1YEV9, A1YG26, A1YG48, A1YG60, A2T712, A2T736, A2T7D2, A2T7L7, A6QPT6, B2KFW1, O14771, O14978, O95125, P10073, P17029, P17040, P59923, Q07231, Q15776, Q16587, Q1LZ87, Q3URR7, Q4KLI1, Q4R8H9, Q53GI3, Q5R670, Q5R741, Q5RJ54, Q5VV52, Q63HK3, Q6A085, Q86W11, Q8BGS3, Q8CF60, Q8IWY8, Q8N393, Q8NF99, Q91VW9, Q969J2, Q96GC6

Diamond homologs: B1H2Q6, G5EGB2, O15535, O75290, P17026, P18724, P18741, P18747, P52742, Q15937, Q17895, Q1LZC0, Q3MJ62, Q4R7X8, Q5R4X5, Q6A085, Q7Z3I7, Q8BGV5, Q8TBZ5, Q91VW9, Q969J2, Q9BRR0, Q9ERU2, Q9ERU3, Q9UEG4, Q9Z1D9, Q9Z2K3, P18715, P18719, P18725, P18729, P18731, P18735, P18737, Q3TDE8, Q966L8, P18714, P18718, P18738, P18740

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 128 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Activation of BAD and translocation to mitochondria762.0×2e-10
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex754.7×4e-10
SARS-CoV-1 targets host intracellular signalling and regulatory pathways754.7×4e-10
Activation of BH3-only proteins740.4×4e-09
SARS-CoV-1-host interactions1326.6×3e-13
RHO GTPases activate PKNs725.8×1e-07
Intrinsic Pathway for Apoptosis723.8×2e-07
SARS-CoV-1 Infection1321.6×9e-13

GO biological processes:

GO termPartnersFoldFDR
cytoplasmic translation1422.0×1e-12
protein targeting515.5×2e-03
ribosomal small subunit biogenesis815.4×1e-05
translation1513.1×2e-10
negative regulation of translation610.0×3e-03
rRNA processing78.4×2e-03
intracellular protein localization87.1×2e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

105 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance94
Likely benign5
Benign2

Top pathogenic / likely-pathogenic (0)

SpliceAI

650 predictions. Top by Δscore:

VariantEffectΔscore
16:30784255:CT:Cacceptor_loss1.0000
16:30784514:CC:Cacceptor_gain1.0000
16:30784515:CC:Cacceptor_gain1.0000
16:30784516:C:CAacceptor_loss1.0000
16:30787027:CGG:Cdonor_gain1.0000
16:30787027:CGGCT:Cdonor_gain1.0000
16:30787080:AAC:Adonor_gain1.0000
16:30787080:AACC:Adonor_gain1.0000
16:30787081:A:Cdonor_gain1.0000
16:30784252:CAC:Cacceptor_gain0.9900
16:30784255:C:CCacceptor_gain0.9900
16:30784404:CCTCA:Cdonor_loss0.9900
16:30784405:CTCAC:Cdonor_loss0.9900
16:30784406:TCA:Tdonor_loss0.9900
16:30784407:CACCT:Cdonor_loss0.9900
16:30784408:A:Tdonor_loss0.9900
16:30784409:C:CAdonor_loss0.9900
16:30784409:CCT:Cdonor_gain0.9900
16:30784511:GGACC:Gacceptor_gain0.9900
16:30784512:GACC:Gacceptor_gain0.9900
16:30784513:ACC:Aacceptor_gain0.9900
16:30784514:CCC:Cacceptor_gain0.9900
16:30784516:C:CCacceptor_gain0.9900
16:30784516:C:Tacceptor_gain0.9900
16:30787021:AACTC:Adonor_loss0.9900
16:30787022:ACTC:Adonor_loss0.9900
16:30787024:TCA:Tdonor_loss0.9900
16:30787025:CA:Cdonor_loss0.9900
16:30787026:A:ACdonor_gain0.9900
16:30787026:AC:Adonor_loss0.9900

AlphaMissense

5757 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
16:30782826:A:GL501P1.000
16:30782843:G:CF495L1.000
16:30782843:G:TF495L1.000
16:30782845:A:GF495L1.000
16:30782927:G:CF467L1.000
16:30782927:G:TF467L1.000
16:30782929:A:GF467L1.000
16:30782982:T:GQ449P1.000
16:30782984:G:CH448Q1.000
16:30782984:G:TH448Q1.000
16:30782986:G:CH448D1.000
16:30782986:G:TH448N1.000
16:30782994:A:GL445P1.000
16:30783011:G:CF439L1.000
16:30783011:G:TF439L1.000
16:30783012:A:GF439S1.000
16:30783013:A:GF439L1.000
16:30783034:A:GC432R1.000
16:30783070:G:CH420D1.000
16:30783078:A:GL417P1.000
16:30783095:G:CF411L1.000
16:30783095:G:TF411L1.000
16:30783097:A:GF411L1.000
16:30783118:A:GC404R1.000
16:30783246:A:GL361P1.000
16:30783263:G:CF355L1.000
16:30783263:G:TF355L1.000
16:30783265:A:GF355L1.000
16:30783308:G:CH340Q1.000
16:30783308:G:TH340Q1.000

dbSNP variants (sampled 300 via entrez): RS1000152871 (16:30778930 T>A,C), RS1000387459 (16:30786774 G>A,C), RS1000611485 (16:30783891 G>A), RS1001054900 (16:30785957 G>A,C), RS1001081345 (16:30782609 C>A,T), RS1001404331 (16:30785490 C>T), RS1001680733 (16:30787870 A>G), RS1001998718 (16:30784037 C>T), RS1002277226 (16:30786404 G>A), RS1002295598 (16:30778202 C>A,T), RS1002347886 (16:30778551 C>A,G,T), RS1002591817 (16:30786091 A>G), RS1003053732 (16:30786229 C>G,T), RS1003055532 (16:30781436 G>A), RS1003117998 (16:30778534 T>C)

Disease associations

OMIM: gene MIM:619587 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST011956_150Systemic lupus erythematosus3.000000e-09

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

26 total (human), top 26 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression2
Valproic Aciddecreases expression, increases methylation2
Cyclosporinedecreases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
GSK-J4decreases expression1
FR900359decreases phosphorylation1
TAK-243decreases sumoylation1
dicrotophosincreases expression1
tris(1,3-dichloro-2-propyl)phosphatedecreases expression1
perfluorooctanoic aciddecreases expression1
benzo(e)pyreneincreases methylation1
ferrous chloridedecreases expression1
perfluorooctane sulfonic aciddecreases expression1
perfluoro-n-nonanoic aciddecreases expression1
perfluorohexanesulfonic aciddecreases expression1
(+)-JQ1 compounddecreases expression1
Leflunomidedecreases expression1
Enzyme Inhibitorsdecreases activity, increases O-linked glycosylation1
Leadaffects expression1
Methapyrileneincreases methylation1
Smokedecreases expression1
Urethanedecreases expression1
Zidovudineaffects cotreatment, increases expression1
Okadaic Aciddecreases expression1
Copper Sulfatedecreases expression1
Acrylamidedecreases expression1

Cellosaurus cell lines

1 cell lines: 1 transformed cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_XW70HEK293 eGFP-ZNF629Transformed cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.